429 related articles for article (PubMed ID: 18983283)
1. Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso.
Mueller JE; Yaro S; Madec Y; Somda PK; Idohou RS; Lafourcade BM; Drabo A; Tarnagda Z; Sangaré L; Traoré Y; Fontanet A; Gessner BD
Trop Med Int Health; 2008 Dec; 13(12):1543-52. PubMed ID: 18983283
[TBL] [Abstract][Full Text] [Related]
2. Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.
Raghunathan PL; Jones JD; Tiendrebéogo SR; Sanou I; Sangaré L; Kouanda S; Dabal M; Lingani C; Elie CM; Johnson S; Ari M; Martinez J; Chatt J; Sidibe K; Schmink S; Mayer LW; Kondé MK; Djingarey MH; Popovic T; Plikaytis BD; Carlone GM; Rosenstein N; Soriano-Gabarró M
J Infect Dis; 2006 Mar; 193(5):607-16. PubMed ID: 16453255
[TBL] [Abstract][Full Text] [Related]
3. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.
Mueller JE; Yaro S; Traore Y; Sangare L; Tarnagda Z; Njanpop-Lafourcade BM; Borrow R; Gessner BD
J Infect Dis; 2006 Mar; 193(6):812-20. PubMed ID: 16479516
[TBL] [Abstract][Full Text] [Related]
4. Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.
Kristiansen PA; Ba AK; Ouédraogo AS; Sanou I; Ouédraogo R; Sangaré L; Diomandé F; Kandolo D; Saga IM; Misegades L; Clark TA; Préziosi MP; Caugant DA
BMC Infect Dis; 2014 Dec; 14():663. PubMed ID: 25472422
[TBL] [Abstract][Full Text] [Related]
5. Meningococcal carriage and immunity in western Burkina Faso, 2003.
Yaro S; Traoré Y; Tarnagda Z; Sangaré L; NjanpopLafourcade BM; Drabo A; Findlow H; Borrow R; Nicolas P; Gessner BD; Mueller JE
Vaccine; 2007 Sep; 25 Suppl 1():A42-6. PubMed ID: 17559988
[TBL] [Abstract][Full Text] [Related]
6. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.
Traoré Y; Njanpop-Lafourcade BM; Adjogble KL; Lourd M; Yaro S; Nacro B; Drabo A; Parent du Châtelet I; Mueller JE; Taha MK; Borrow R; Nicolas P; Alonso JM; Gessner BD
Clin Infect Dis; 2006 Oct; 43(7):817-22. PubMed ID: 16941360
[TBL] [Abstract][Full Text] [Related]
7. Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity.
Mueller JE; Yaro S; Njanpop-Lafourcade BM; Drabo A; Idohou RS; Kroman SS; Sanou O; Diagbouga S; Traoré Y; Sangaré L; Borrow R; Gessner BD
J Infect Dis; 2011 Dec; 204(11):1787-95. PubMed ID: 21998478
[TBL] [Abstract][Full Text] [Related]
8. Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.
Kristiansen PA; Diomandé F; Wei SC; Ouédraogo R; Sangaré L; Sanou I; Kandolo D; Kaboré P; Clark TA; Ouédraogo AS; Absatou KB; Ouédraogo CD; Hassan-King M; Thomas JD; Hatcher C; Djingarey M; Messonnier N; Préziosi MP; LaForce M; Caugant DA
Clin Vaccine Immunol; 2011 Mar; 18(3):435-43. PubMed ID: 21228139
[TBL] [Abstract][Full Text] [Related]
9. Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine.
Topaz N; Kristiansen PA; Schmink S; Congo-Ouédraogo M; Kambiré D; Mbaeyi S; Paye M; Sanou M; Sangaré L; Ouédraogo R; Wang X
Microb Genom; 2020 Dec; 6(12):. PubMed ID: 33332261
[TBL] [Abstract][Full Text] [Related]
10. The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002.
Koumaré B; Ouedraogo-Traoré R; Sanou I; Yada AA; Sow I; Lusamba PS; Traoré E; Dabal M; Santamaria M; Hacen MM; Kaboré AB; Caugant DA
Vaccine; 2007 Sep; 25 Suppl 1():A37-41. PubMed ID: 17521783
[TBL] [Abstract][Full Text] [Related]
11. ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study.
Sié A; Pflüger V; Coulibaly B; Dangy JP; Kapaun A; Junghanss T; Pluschke G; Leimkugel J
Trop Med Int Health; 2008 Jun; 13(6):861-8. PubMed ID: 18384478
[TBL] [Abstract][Full Text] [Related]
12. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.
Kristiansen PA; Diomandé F; Ba AK; Sanou I; Ouédraogo AS; Ouédraogo R; Sangaré L; Kandolo D; Aké F; Saga IM; Clark TA; Misegades L; Martin SW; Thomas JD; Tiendrebeogo SR; Hassan-King M; Djingarey MH; Messonnier NE; Préziosi MP; Laforce FM; Caugant DA
Clin Infect Dis; 2013 Feb; 56(3):354-63. PubMed ID: 23087396
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana.
Gagneux SP; Hodgson A; Smith TA; Wirth T; Ehrhard I; Morelli G; Genton B; Binka FN; Achtman M; Pluschke G
J Infect Dis; 2002 Mar; 185(5):618-26. PubMed ID: 11865418
[TBL] [Abstract][Full Text] [Related]
14. Meningococcal carriage within households in the African meningitis belt: A longitudinal pilot study.
Basta NE; Berthe A; Keita M; Onwuchekwa U; Tamboura B; Traore A; Hassan-King M; Manigart O; Nascimento M; Stuart JM; Trotter C; Blake J; Carr AD; Gray SJ; Newbold LS; Deng Y; Wolfson J; Halloran ME; Greenwood B; Borrow R; Sow SO
J Infect; 2018 Feb; 76(2):140-148. PubMed ID: 29197599
[TBL] [Abstract][Full Text] [Related]
15. Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo.
Traore Y; Tameklo TA; Njanpop-Lafourcade BM; Lourd M; Yaro S; Niamba D; Drabo A; Mueller JE; Koeck JL; Gessner BD
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S181-9. PubMed ID: 19191614
[TBL] [Abstract][Full Text] [Related]
16. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing.
Parent du Châtelet I; Traore Y; Gessner BD; Antignac A; Naccro B; Njanpop-Lafourcade BM; Ouedraogo MS; Tiendrebeogo SR; Varon E; Taha MK
Clin Infect Dis; 2005 Jan; 40(1):17-25. PubMed ID: 15614687
[TBL] [Abstract][Full Text] [Related]
17. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
Mueller JE; Borrow R; Gessner BD
Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.
Kristiansen PA; Ba AK; Sanou I; Ouédraogo AS; Ouédraogo R; Sangaré L; Diomandé F; Kandolo D; Thomas JD; Clark TA; Laforce M; Caugant DA
BMC Infect Dis; 2013 Aug; 13():363. PubMed ID: 23914778
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso.
Yaro S; Lourd M; Traoré Y; Njanpop-Lafourcade BM; Sawadogo A; Sangare L; Hien A; Ouedraogo MS; Sanou O; Parent du Châtelet I; Koeck JL; Gessner BD
Clin Infect Dis; 2006 Sep; 43(6):693-700. PubMed ID: 16912941
[TBL] [Abstract][Full Text] [Related]
20. [The prevalence of nasopharyngeal Neisseria meningitidis carriage, serogroup distribution, and antibiotic resistance among healthy children in Cankaya municipality schools of Ankara province].
Ercis S; Köseoğlu O; Salmanzadeh-Ahrabi S; Ercis M; Akin L; Hasçelik C
Mikrobiyol Bul; 2005 Oct; 39(4):411-20. PubMed ID: 16544542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
